Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

NCT06563375 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: NP-101

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]